Andrew D. RuskinPartnerK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmailTwitterLinkedIn202-778-9415 Professional Biography Andrew Ruskin is a partner in the firm’s Washington, D.C. office. He is a member of the health care and FDA practice group. Areas of Focus Health Care and FDA Food, Drugs, Medical Devices, and Cosmetics (FDA) More Legal and Business Bylines From Andrew D. Ruskin An Update on the CMS Hospital Price Transparency Rule [PODCAST] - (Posted On Thursday, October 21, 2021) CMS Proposes to Increase Penalties for Hospital Price Transparency Noncompliance - (Posted On Thursday, July 22, 2021) 340B Update: Supreme Court Accepts Certiorari in 340B Payment Reduction Case - (Posted On Thursday, July 08, 2021) 340B Update: Delaware Court Denies 340B Program Statute Requiring Contract Pharmacy Arrangements - (Posted On Wednesday, July 07, 2021) 340B Update: Federal Court Halts 340B Administrative Dispute Resolution Rule - (Posted On Monday, March 29, 2021) Hospitals Ask Supreme Court to Reverse Site-Neutral, 340B Payment Rulings - (Posted On Thursday, March 25, 2021) 340B Drug Pricing Program 2021 Outlook [PODCAST] - (Posted On Friday, March 19, 2021) COVID-19: Reimbursement Corner: Graduate Medical Education Gets Major Boost From Congressional Appropriations Bill - (Posted On Wednesday, December 23, 2020) 340B Update: HRSA Moves Forward with 340B ADR Rule as Covered Entities Challenge Contract Pharmacy Actions [PODCAST] - (Posted On Thursday, December 03, 2020) OIG Finalizes Rebate Rules: Removal of Safe Harbor Protections for Rebates and Creation of New Safe Harbors for Other Discounts and Service Fees - (Posted On Wednesday, December 02, 2020) Pagination Previous page ‹ Previous Page 2 Next page Next › Current Legal Analysis EPA Releases Guides to Assist Users with the MyPeST Platform for Pesticide Submission by: Heather F. Collins, MS House Bill Would Establish Dedicated Biotechnology Official in State Department by: Lynn L. Bergeson , Carla N. Hutton OMB Extends Section 503 Data Collection Amid Pending Regulatory Changes by: Laura A. Mitchell , Scott M. Pechaitis Navigating Nuclear: Updates in New York by: Tison A. Campbell , Julie G. Ezell First-Ever Section 338 Tariffs: U.S. Imposes 50% Duties on Nearly $20 Billion of Canadian Imports by: Deanna Tanner Okun , Dominic L. Bianchi A VERY BITTER PILL TO SWALLOW – Vivek Shah Declared a Vexatious Litigant by: Oliver Shapiro DHS Rescinds 2022 Public Charge Rule by: Katherine C. MacIlwaine , Nicole Fink Senate Proposal Would Mandate New “Connect and Manage” Approach to Grid Interconnections by: Ted J. Murphy , Frederick R. Eames NJ Gov: 6,000 Non-Citizens Registered to Vote. Registration Failure Demands Accountability—Not Political Spin. by: Raymond G. Lahoud What Every Multinational Should Know About … The DOJ Escalation of Customs and Tariff Enforcement by: Gregory Husisian , Matthew D. Krueger Second Circuit Upholds Effectiveness of Section 16 Beneficial Ownership Blockers by: Scott Budlong , Brittany McCants New TPS Placeholder Dates for Multiple Countries Set by Court Order by: Amy L. Peck , Danielle Kutinsky More I-94 Monitoring + Timely EOS Filing for Employers as DHS Reshapes F-1 and J-1 Framework by: Otieno B. Ombok , Amy L. Peck Colorado’s New Identity Document Law Adds Employer Compliance Obligations by: Amy L. Peck Updated MOU between USDA, HHS, and EPA Addresses Drug Residues, Pesticide Residues, and Chemical Contaminants in Food by: Lynn L. Bergeson , James V. Aidala Upcoming Events Sep 14-16 2026 Private Wealth Management Summit by Marcus Evans Sep 17-18 2026 Chief Litigation Officer Summit by Marcus Evans Sep 17-18 2026 IP Law Summit by Marcus Evans Oct 19-20 2026 European Corporate Counsel Summit by Marcus Evans Print
